JCR PharmaceuticalsJCR Pharmaceuticals Co.,Ltd.4552東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

JCR Pharmaceuticals FY ending Mar 2020 results

JCR Pharmaceuticals brought in ¥24.8B in revenue.

Out of every ¥100 of sales, about ¥13 is left as operating profit.

Where the money goes

For every ¥100 JCR Pharmaceuticals sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 68.1% → Operating margin 13.1% → Net margin 10.8%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第49期(2023/04/01－2024/03/31)
ID S100TQM62024-06-26Open
EDINET (FSA Japan)
有価証券報告書－第47期(令和3年4月1日－令和4年3月31日)
ID S100OAJT2022-06-22Open
EDINET (FSA Japan)
有価証券報告書－第46期(令和2年4月1日－令和3年3月31日)
ID S100LL7F2021-06-23Open

Extracted from XBRL: 49 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.